Literature DB >> 23130329

Immediate hypersensitivity reactions to IV non-ionic iodinated contrast in computed tomography.

Jonathan Ho1, Roger J Kingston, Noel Young, Constance H Katelaris, Doungkamol Sindhusake.   

Abstract

BACKGROUND: With use of computed tomography (CT), intravenous contrast media is used routinely to help define anatomy and identify any pathology. Non-ionic iodinated contrast agents have largely replaced ionic agents and although rare, reactions to contrast are still important and more so with the continual increase in CT examinations in the last decade.
OBJECTIVE: To examine the incidence, severity and risk factors of immediate hypersensitivity reactions to intravenous non-ionic iodinated contrast in CT.
METHODS: Data of consecutive patients in an Australian tertiary hospital who developed immediate hypersensitivity reactions to intravenous iopromide during CT were collected and compared with the results of all contrast CTs performed over a four year period. Chi-square statistics and odds ratio are calculated on the variables of age, gender, referral source and seasons of the study.
RESULTS: Forty-seven patients had immediate hypersensitivity reactions of 29,962 patients who underwent contrast CT (0.16%). Thirty-three patients (70%) had a mild reaction, 11 (23%) moderate and three (7%) severe. Sixteen (34%) were male and 31 (66%) were female. Sixty-eight percent were under 55-years of age. Reactions occurred in 0.35% (34 patients) of all outpatients, 0.07% (6 patients) of all emergency patients, and 0.06% (7 patients) of all in-patients. Eighteen (38%) occurred in spring, seven (15%) in summer, 17 (36%) in autumn and five (11%) in winter. There is a statistically significant higher risk of contrast reactions in females (Odds Ratio [OR] 2.41 p = 0.005), patients younger than 55-years old (OR 2.46, p = 0.005), outpatients (OR 5.42, p < 0.001) and CTs performed in spring and autumn (OR 2.77, p = 0.002).
CONCLUSION: The incidence of immediate hypersensitivity reactions in contrast CT is low and mostly mild. Risk factors include female, younger than 55-years of age, outpatients and CT examinations performed in spring and autumn. This is the first study to observe such a seasonal variation.

Entities:  

Keywords:  Allergy; Computed tomography; IV contrast; Seasons

Year:  2012        PMID: 23130329      PMCID: PMC3486968          DOI: 10.5415/apallergy.2012.2.4.242

Source DB:  PubMed          Journal:  Asia Pac Allergy        ISSN: 2233-8276


  15 in total

1.  Seasonal variation in the occurrence of late adverse skin reactions to iodine-based contrast media.

Authors:  R Mikkonen; T Vehmas; H Granlund; L Kivisaari
Journal:  Acta Radiol       Date:  2000-07       Impact factor: 1.990

Review 2.  Anaphylactoid reactions to radiocontrast media.

Authors:  Lauren M Canter
Journal:  Allergy Asthma Proc       Date:  2005 May-Jun       Impact factor: 2.587

3.  The risks of death and of severe nonfatal reactions with high- vs low-osmolality contrast media: a meta-analysis.

Authors:  J J Caro; E Trindade; M McGregor
Journal:  AJR Am J Roentgenol       Date:  1991-04       Impact factor: 3.959

4.  Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media.

Authors:  H Katayama; K Yamaguchi; T Kozuka; T Takashima; P Seez; K Matsuura
Journal:  Radiology       Date:  1990-06       Impact factor: 11.105

5.  The RACR survey of intravenous contrast media reactions. Final report.

Authors:  F J Palmer
Journal:  Australas Radiol       Date:  1988-11

6.  Trends in adverse events after IV administration of contrast media.

Authors:  S T Cochran; K Bomyea; J W Sayre
Journal:  AJR Am J Roentgenol       Date:  2001-06       Impact factor: 3.959

7.  Frequency and severity of adverse effects of iodinated and gadolinium contrast materials: retrospective review of 456,930 doses.

Authors:  Christopher H Hunt; Robert P Hartman; Gina K Hesley
Journal:  AJR Am J Roentgenol       Date:  2009-10       Impact factor: 3.959

8.  Mechanisms of severe, immediate reactions to iodinated contrast material.

Authors:  D Laroche; I Aimone-Gastin; F Dubois; H Huet; P Gérard; M C Vergnaud; C Mouton-Faivre; J L Guéant; M C Laxenaire; H Bricard
Journal:  Radiology       Date:  1998-10       Impact factor: 11.105

9.  Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients.

Authors:  A F Kopp; K J Mortele; Y D Cho; P Palkowitsch; M A Bettmann; C D Claussen
Journal:  Acta Radiol       Date:  2008-10       Impact factor: 1.990

10.  Nonionic iodinated intravenous contrast material-related reactions: incidence in large urban children's hospital--retrospective analysis of data in 12,494 patients.

Authors:  Michael J Callahan; Linda Poznauskis; David Zurakowski; George A Taylor
Journal:  Radiology       Date:  2009-03       Impact factor: 11.105

View more
  5 in total

1.  Contrast Media Adverse Drug Reactions in Highly Polluted Environment.

Authors:  Natalia Sauer; Wojciech Szlasa; Laura Jonderko; Krystyna Głowacka; Katarzyna Karłowicz-Bodalska; Anna Wiela-Hojeńska
Journal:  Int J Environ Res Public Health       Date:  2022-06-09       Impact factor: 4.614

2.  Risk of Hypersensitivity Reactions to Iopromide in Children and Elderly: An Analysis of 132,850 Patients From 4 Observational Studies and Pharmacovigilance Covering >288 Million Administrations.

Authors:  Jan Endrikat; Julia Chernova; Christoph Gerlinger; Marcin Pracz; Philipp Lengsfeld; Aasia Bhatti; Alexander Michel
Journal:  Invest Radiol       Date:  2022-05-01       Impact factor: 6.016

3.  Implementation of guidelines, allergy programs, and the October issue.

Authors:  Yoon-Seok Chang
Journal:  Asia Pac Allergy       Date:  2012-10-31

4.  Free air on plain film: Do we need a computed tomography too?

Authors:  Carolina V Solis; Yuchiao Chang; Marc A De Moya; George C Velmahos; Peter J Fagenholz
Journal:  J Emerg Trauma Shock       Date:  2014-01

Review 5.  Radiocontrast media hypersensitivity in the Asia Pacific region.

Authors:  Suh-Young Lee; Kyoung-Whan Lim; Yoon-Seok Chang
Journal:  Asia Pac Allergy       Date:  2014-04-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.